Medivir AB (FRA:MVR0)
€ 0.211 -0.017 (-7.46%) Market Cap: 27.91 Mil Enterprise Value: 14.54 Mil PE Ratio: 0 PB Ratio: 1.77 GF Score: 46/100

Q1 2022 Medivir AB Earnings Call Transcript

Apr 28, 2022 / 01:00PM GMT
Release Date Price: €0.59733 (-0.42%)
Operator

Hello, and welcome to the Medivir Audiocast Teleconference Q1 2022. (Operator Instructions)

Today, I'm pleased to have CEO, Jens Lindberg. Please begin.

Jens Lindberg;publ;CEO
Medivir AB

()-

Thank you, and welcome, everyone, to our quarter 1 call 2022. If we move to the next slide, please, Slide #2. There will be 3 of us presenting. So with me in the room here at Medivir is Magnus Christensen, our CFO, who will cover the financials towards the end. And in the room with me as well is Fredrik Ãberg, our Chief Scientific Officer, and Fredrik will cover the sort of the more data and science-driven slides sort of during the presentation today. And I will kick things off with a bit of an overview.

If we move to Slide #3, please. As always, important information, and I will not go through it in detail. It's part of our presentation, and you find our presentation on our website as well. So please have a look there in terms of the more details of this part.

So with that, we can move 2 slides forward to Slide

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot